464 related articles for article (PubMed ID: 11600887)
1. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
2. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
4. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
5. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
6. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
8. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
9. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
[TBL] [Abstract][Full Text] [Related]
10. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
[TBL] [Abstract][Full Text] [Related]
11. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
13. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
[TBL] [Abstract][Full Text] [Related]
14. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
Guéry JC; Galbiati F; Smiroldo S; Adorini L
J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
[TBL] [Abstract][Full Text] [Related]
15. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
Soldera S; McSorley SJ; Glaichenhaus N
Eur J Immunol; 1997 Apr; 27(4):848-54. PubMed ID: 9130634
[TBL] [Abstract][Full Text] [Related]
16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
17. Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection.
Suzue K; Kobayashi S; Takeuchi T; Suzuki M; Koyasu S
Int Immunol; 2008 Mar; 20(3):337-43. PubMed ID: 18195051
[TBL] [Abstract][Full Text] [Related]
18. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice.
Doherty TM; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):124-35. PubMed ID: 8932762
[TBL] [Abstract][Full Text] [Related]
19. The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling.
Louis JA; Gumy A; Voigt H; Launois P; Rocken M
Pathol Biol (Paris); 2003 Mar; 51(2):71-3. PubMed ID: 12801805
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]